Overview Financials News + Filings Key Docs Ownership Insiders
|
|
MiNK Therapeutics, Inc.
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | 10-K | S-1/A |
| Revenues | | | 100.0% | 100.0% |
| Cost of goods sold | | | 0.0% | 2776.3% |
| Gross profit | | | 100.0% | -2676.3% |
| Research and development | | | -247.6% | |
| General and administrative | | | -33.5% | 555.1% |
| Depreciation | | | -1.4% | 5.3% |
| EBIT | | | 381.1% | -3231.4% |
| Pre-tax income | | | 422.8% | -3451.5% |
| Income taxes | | | 0.0% | 0.0% |
| Net income | | | 422.8% | -3451.5% |
|